ArticleRSC advances2018
Novel caffeoylquinic acid derivatives from
Article in RSC advances, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 62 citations in OpenAlex.
- Insights into the Health-Promoting Properties and Nutraceutical and Food Applications ofMolecules (Basel, Switzerland) · 2026Review
- Phytochemical Composition, Bioactivities, and Medicinal Value ofMolecules (Basel, Switzerland) · 2026Review
- Honeysuckle as a Food-Medicine Resource: A Review of Its Multi-Target Pharmacological Effects and Emerging Applications.Molecules (Basel, Switzerland) · 2026Review
- Discovering the Anti-Inflammatory Potential of Compounds Isolated from the Aerial Parts ofMolecules (Basel, Switzerland) · 2025Article
- Integrative Discovery Through Network Pharmacology and Molecular Docking Approaches of Phenolic Compounds Isolated fromInternational journal of molecular sciences · 2025Article
- Comparative evaluation of three herbal extracts on growth performance, immune response, and resistance against Vibrio parahaemolyticus in Litopenaeus vannamei.BMC veterinary research · 2025Article
- Isolation of Potent 5α-Reductase Inhibitors and Antioxidants from Sphaeranthus indicus Linn. for the Management of Benign Prostatic Hyperplasia.Plant foods for human nutrition (Dordrecht, Netherlands) · 2024Article
- Ultrasonic-Assisted Extraction of Phenolic Compounds fromMolecules (Basel, Switzerland) · 2024Article
- Evaluation of Anti-Molecules (Basel, Switzerland) · 2023Article
- Water Extract of DesaltedNutrients · 2023Article
- Anti-Wrinkling Effect of 3,4,5-tri-Antioxidants (Basel, Switzerland) · 2023Article
- JFD, a Novel Natural Inhibitor of Keap1 Alkylation, Suppresses IntracellularOxidative medicine and cellular longevity · 2023Article
- Advances in Production of Hydroxycinnamoyl-Quinic Acids: From Natural Sources to Biotechnology.Antioxidants (Basel, Switzerland) · 2022Review
- Antimicrobial Secondary Metabolites from the Mangrove Plants of Asia and the Pacific.Marine drugs · 2022Review
- Analysis of Antioxidant Constituents fromAntioxidants (Basel, Switzerland) · 2022Article
- Effect of Blanching and Boiling on the Secondary Metabolism of Cultivated Cardoon Stalks: A Case Study of the Tuscany Region (Italy).Metabolites · 2022Article
- Leafy Stems ofMetabolites · 2021Article
- Characterization of Caffeoylquinic Acids fromACS omega · 2020Article
- Isolation of Antimicrobial Compounds FromFrontiers in microbiology · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.